Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andreia C de Melo"'
Autor:
Andreia C de Melo, Luiz C S Thuler, Jesse L da Silva, Lucas Z de Albuquerque, Ana C Pecego, Luciana de O R Rodrigues, Magda S da Conceição, Marianne M Garrido, Gelcio L Quintella Mendes, Ana Cristina P Mendes Pereira, Marcelo A Soares, João P B Viola, Brazilian National Cancer Institute COVID-19 Task Force
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241261 (2020)
ObjectiveThis study aimed to describe the demographic and clinical characteristics of cancer inpatients with COVID-19 exploring clinical outcomes.MethodsA retrospective search in the electronic medical records of cancer inpatients admitted to the Bra
Externí odkaz:
https://doaj.org/article/abbafc9350354a9eb9d7a2ebe0cac8ad
Autor:
Aline B. Lara Gongora, Gustavo Werutsky, Denis L. Jardim, Angelica Nogueira-Rodrigues, Carlos H. Barrios, Clarissa Mathias, Fernando Maluf, Rachel Riechelmann, Maurício Fraga, Henry Gomes, William N. William, Camilla A. F. Yamada, Gilberto de Castro Jr, Daniela D. Rosa, Andreia C. de Melo, Raul Sala, Eva Bustamante, Denisse Bretel, Oscar Arrieta, Andrés F. Cardona, Diogo A. Bastos
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 649-658 (2021)
PURPOSECOVID-19 has affected cancer care worldwide. Clinical trials are an important alternative for the treatment of oncologic patients, especially in Latin America, where trials can be the only opportunity for some of them to access novel and, some
Externí odkaz:
https://doaj.org/article/c6436c3390d04fb48eb100f0ab3f6c2c
Autor:
Krishnansu S, Tewari, Bradley J, Monk, Ignace, Vergote, Austin, Miller, Andreia C, de Melo, Hee-Seung, Kim, Yong Man, Kim, Alla, Lisyanskaya, Vanessa, Samouëlian, Domenica, Lorusso, Fernanda, Damian, Chih-Long, Chang, Evgeniy A, Gotovkin, Shunji, Takahashi, Daniella, Ramone, Joanna, Pikiel, Beata, Maćkowiak-Matejczyk, Eva M, Guerra Alía, Nicoletta, Colombo, Yulia, Makarova, Danny, Rischin, Stephanie, Lheureux, Kosei, Hasegawa, Keiichi, Fujiwara, Jingjin, Li, Shaheda, Jamil, Vladimir, Jankovic, Chieh-I, Chen, Frank, Seebach, David M, Weinreich, George D, Yancopoulos, Israel, Lowy, Melissa, Mathias, Matthew G, Fury, Ana, Oaknin, Rachna T, Shroff
Publikováno v:
Obstetrical & Gynecological Survey. 77:348-350
Background: Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)-blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a61b695632bb95081113f9be0c7c4b18
https://doi.org/10.1097/01.ogx.0000834600.51705.68
https://doi.org/10.1097/01.ogx.0000834600.51705.68